![Ajay Kumar Sharma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ajay Kumar Sharma
Directeur Financier/CFO chez
MOREPEN LABORATORIES LIMITED
Profil
Mr. Ajay Kumar Sharma is a Chief Financial Officer at Morepen Laboratories Ltd. and a Chief Financial Officer & Director at Dr. Morepen Ltd. He is on the Board of Directors at Dr. Morepen Ltd.
Postes actifs de Ajay Kumar Sharma
| Sociétés | Poste | Début |
|---|---|---|
| MOREPEN LABORATORIES LIMITED | Directeur Financier/CFO | 03/04/2002 |
Dr. Morepen Ltd.
 Dr. Morepen Ltd. Part of Morepen Laboratories Ltd., Dr. Morepen Ltd. is a pharmaceutical company specializing in active pharmaceutical ingredients (APIs), finished formulations, diagnostics, and over-the-counter healthcare products. The company operates manufacturing facilities, including a large complex in Baddi with 10 specialized plants, producing generic bulk drugs such as montelukast, loratadine, atorvastatin, and rosuvastatin. The company maintains over 100 product combinations, 54 patents, and serves regulated and non-regulated markets in more than 75 countries. It offers finished formulations and nutraceuticals under brands such as Dr. Morepen and Gubb World, and has a presence in home health diagnostics with over 14 million glucometers installed worldwide. The company is based in New Delhi, India. The company was founded in 2001. Dr. Morepen focuses on research and development for new molecule development and non-infringing technologies, supporting a broad product pipeline across therapeutic areas like anti-diabetic, anti-psychotic, and cardiology. The CEO is Sanjay Suri. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Morepen Laboratories Ltd.
 Morepen Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures generic drugs and pharmaceutical formulations | Health Technology |
Dr. Morepen Ltd.
Dr. Morepen Ltd. Part of Morepen Laboratories Ltd., Dr. Morepen Ltd. is a pharmaceutical company specializing in active pharmaceutical ingredients (APIs), finished formulations, diagnostics, and over-the-counter healthcare products. The company operates manufacturing facilities, including a large complex in Baddi with 10 specialized plants, producing generic bulk drugs such as montelukast, loratadine, atorvastatin, and rosuvastatin. The company maintains over 100 product combinations, 54 patents, and serves regulated and non-regulated markets in more than 75 countries. It offers finished formulations and nutraceuticals under brands such as Dr. Morepen and Gubb World, and has a presence in home health diagnostics with over 14 million glucometers installed worldwide. The company is based in New Delhi, India. The company was founded in 2001. Dr. Morepen focuses on research and development for new molecule development and non-infringing technologies, supporting a broad product pipeline across therapeutic areas like anti-diabetic, anti-psychotic, and cardiology. The CEO is Sanjay Suri. |
Choisissez Zonebourse 
